Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 300, Issue 1-2, 2011, Pages 81-85

  Kalinowska Łyszczarz, Alicja ^a   Szczuciński, Adam ^a   Pawlak, Mikołaj A ^a   Losy, Jacek ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

CCL17; CCL20; Chemokines; CXCL13; IL 17; Multiple sclerosis

Indexed keywords

CXCL13 CHEMOKINE; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TH17 CELL;

ADULT; ANTI-INFLAMMATORY AGENTS; CHEMOKINE CCL17; CHEMOKINE CCL20; CHEMOKINE CXCL13; CHEMOKINES; FEMALE; HUMANS; INTERLEUKIN-17; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; ROC CURVE; TENSION-TYPE HEADACHE;

EID: 78650516882     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.09.026     Document Type: Article

References (47)

1. L.K. Peterson, and R.S. Fujinami Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis J Neuroimmunol 184 2007 37 44 (Pubitemid 46389415)
2. L.P. Rowland, Merritt's Neurology 11th edition 2005 Lippincott Williams & Wilkins Philadelphia, USA
3. C. Bjartmar, G. Kidd, S. Mörk, R. Rudick, and B.D. Trapp Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients Ann Neurol 48 2000 893 901
4. D. Franciotta, M. Salvetti, F. Lolli, B. Serafini, and F. Aloisi B cells and multiple sclerosis Lancet Neurol 7 2008 852 858
5. I.F. Charo, and R.M. Ransohoff The many roles of chemokines and chemokine receptors in inflammation N Engl J Med 354 2006 610 621
6. A. Szczuciński, and J. Losy Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies Acta Neurol Scand 115 2007 137 146 (Pubitemid 46219205)
7. Gunn, V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cyster, and L.T. Williams A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 Nature 391 1998 799 803 (Pubitemid 28099679)
8. C.H. Jenh, M.A. Cox, W. Hipkin, T. Lu, C. Pugliese-Sivo, and W. Gonsiorek Human B cell-attracting chemokine 1 (BCA-1; CXCL13) is an agonist for the human CXCR3 receptor Cytokine 15 2001 113 121 (Pubitemid 34587493)
9. M. Krumbholz, D. Theil, S. Cepok, B. Hemmer, P. Kivisäkk, and R.M. Ransohoff Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment Brain 129 2006 200 211 (Pubitemid 43063771)
10. G. Michałowska-Wender, J. Losy, J. Biernacka-Łukanty, and M. Wender Impact of methylprednisolone treatment on the expression of macrophage inflammatory protein 3alpha and B lymphocyte chemoattractant in serum of multiple sclerosis patients Pharmacol Rep 60 2008 549 554
11. E. Ambrosini, M.E. Remoli, E. Giacomini, B. Rosicarelli, B. Serafini, and R. Lande Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions J Neuropathol Exp Neurol 64 2005 706 715 (Pubitemid 41179012)
12. R. Furlan, M. Rovaris, F. Martinelli-Boneschi, M. Khademi, A. Bergami, and M. Gironi Immunological patterns identifying disease course and evolution in multiple sclerosis patients J Neuroimmunol 165 2005 192 200 (Pubitemid 40984638)
13. C.A. Power, D.J. Church, A. Meyer, S. Alouani, A.E. Proudfoot, and I. Clark-Lewis Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3a from lung dendritic cells J Exp Med 186 1997 825 835 (Pubitemid 27407344)
14. F. Liao, R.L. Rabin, C.S. Smith, G. Sharma, T.B. Nutman, and J.M. Farber CC-Chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α J Immunol 162 1999 186 194 (Pubitemid 29018919)
15. R.E. Kohler, A.C. Caon, D.O. Willenborg, I. Clark-Lewis, and S.R. McColl A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system J Immunol 170 2003 6298 6306 (Pubitemid 36682616)
16. E. Ambrosini, S. Columba-Cabezas, B. Serafini, A. Muscella, and F. Aloisi Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro Glia 41 2003 290 300 (Pubitemid 36258473)
17. A. Reboldi, C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, and S. Lira C-C chemokine receptor 6-regulated entry of T(H)-17 cells into the CNS through the choroid plexus is required for the initiation of EAE Nat Immunol 10 2009 514 523
18. C.B. Schmidt-Weber, M. Akdis, and C.A. Akdis TH17 cells in the big picture of immunology J Allergy Clin Immunol 120 2007 247 254
19. J.S. Tzartos, M.A. Friese, M.J. Craner, J. Palace, J. Newcombe, and M.M. Esiri Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis Am J Pathol 172 2008 146 155 (Pubitemid 351186376)
20. D. Matusevicius, P. Kivisakk, B. He, N. Kostulas, V. Ozenci, and S. Fredrikson Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis Mult Scler 5 1999 101 104 (Pubitemid 29186827)
21. H. Kebir, K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, and M. Bernard Human T(H)17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation Nat Med 13 2007 1173 1175 (Pubitemid 47530640)
22. T. Ishizu, M. Osoegawa, F.J. Mei, H. Kikuchi, M. Tanaka, and Y. Takakura Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis Brain 128 2005 988 1002 (Pubitemid 40675455)
23. G. Saruhan-Direskeneli, S.P. Yentür, G. Akman-Demir, N. Işik, and P. Serdaroǧlu Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases J Neuroimmunol 145 2003 127 134 (Pubitemid 37485973)
24. E.V. Acosta-Rodriguez, L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, and A. Lanzavecchia Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells Nat Immunol 8 2007 639 646 (Pubitemid 46785128)
25. K. Narikawa, T. Misu, K. Fujihara, I. Nakashima, S. Sato, and Y. Itoyama CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis J Neuroimmunol 149 2004 182 186 (Pubitemid 38352871)
26. O. Yoshie, T. Imai, and H. Nomiyama Novel lymphocyte-specific CC chemokines and their receptors J Leukoc Biol 62 1997 634 644 (Pubitemid 27519774)
27. G. Bernardini, J. Hedrick, S. Sozzani, W. Luini, G. Spinetti, and M. Weiss Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor Eur J Immunol 28 1998 582 588 (Pubitemid 28101735)
28. D. D'Ambrosio, A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, and A. Mantovani Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells J Immunol 161 1998 5111 5115 (Pubitemid 28519063)
29. C.H. Polman, S.C. Reingold, G. Edan, M. Filippi, H.P. Hartung, and L. Kappos Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 2005 840 846 (Pubitemid 41746873)
30. Tobias Sing, Oliver Sander, Niko Beerenwinkel, and Thomas Lengauer ROCR: visualizing classifier performance in R Bioinformatics 21 2005 3940 3941 (Pubitemid 41535515)
31. B. Serafini, B. Rosicarelli, R. Magliozzi, E. Stigliano, and F. Aloisi Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol 14 2004 164 174 (Pubitemid 38656388)
32. R. Magliozzi, O. Howell, A. Vora, B. Serafini, R. Nicholas, and M. Puopolo Meningeal B-cell follices in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology Brain 130 2007 1089 1104 (Pubitemid 47355604)
33. J.L. Gommerman, and J.L. Browning Lymphotoxin/light, lymphoid microenvironments and autoimmune disease Nat Rev Immunol 3 2003 642 655
34. V.N. Ngo, H. Korner, M.D. Gunn, K.N. Schmidt, D.S. Riminton, and M.D. Cooper Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T-cell areas of the spleen J Exp Med 189 1999 403 412 (Pubitemid 29063261)
35. L. Fan, C.R. Reilly, Y. Luo, M.E. Dorf, and D. Lo Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis J Immunol 164 2000 3955 3959 (Pubitemid 30215047)
36. P. Hjelmstrom, J. Fjell, T. Nakagawa, R. Sacca, C.A. Cuff, and N.H. Ruddle Lymphoid tissue homing chemokines are expressed in chronic inflammation Am J Pathol 156 2000 1133 1138 (Pubitemid 30659989)
37. N.H. Ruddle Lymphoid neo-organogenesis: lymphotoxin's role in inflammation and development Immunol Res 19 1999 119 125
38. E. Bettelli, M. Oukka, and V.K. Kuchroo TH-17 cells in the circle of immunity and autoimmunity Nat Immunol 8 2007 345 350 (Pubitemid 46745409)
39. E. Bettelli, T. Korn, and V.K. Kuchroo Th17: the third member of the effector T cell trilogy Curr Opin Immunol 19 2007 652 657 (Pubitemid 350236805)
40. H17 and regulatory T cells Nature 441 2006 235 238
41. D.V. Jovanovic, J.A. Di Battista, J. Martel-Pelletier, F.C. Jolicoeur, Y. He, and M. Zhang IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages J Immunol 160 1998 3513 3521 (Pubitemid 28164746)
42. S. Haak, A.L. Croxford, K. Kreymborg, F.L. Heppner, S. Pouly, and B. Becher IL-17A and IL-17 F do not contribute vitally to autoimmune neuro-inflammation in mice J Clin Invest 119 2009 61 69
43. J.S. Sloka, and M. Stefanelli The mechanism of action of methylprednisolone in the treatment of multiple sclerosis Mult Scler 11 2005 425 432 (Pubitemid 40984237)
44. H. Bartosik-Psujek, and Z. Stelmasiak Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse Eur Neurol 52 2004 237 241
45. M.A. Moreira, C.P. Tilbery, L.P. Monteiro, and A.L. Teixeira Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis Acta Neurol Scand 114 2006 109 113 (Pubitemid 44034258)
46. T.L. Sørensen, F. Sellebjerg, C.V. Jensen, R.M. Strieter, and R.M. Ransohoff Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis Eur J Neurol 8 2001 665 672 (Pubitemid 35015232)
47. P. Stutzer, and J. Kesselring Wilhelm Uhthoff: a phenomenon 1853 to 1927 Int MS J 15 2008 90 93